Specifically, seminoma samples showed strong immunoreactivity for TP53, CD8A, STAT1, PTPRC, CCL5, and MYD88, while teratoma tissues exhibited heightened expression of HSP90AA1, TOP2A, HSP4A, CDK1, CCNB1, and TRIM28. This evidence concerns the gene CCNB1 and teratoma.